Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF

INTRODUCTION: Heart failure with preserved ejection fraction (HFpEF), which is a common co-morbidity in patients with maintenance hemodialysis (MHD), results in substantial mortality and morbidity. However, there are still no effective therapeutic drugs available for HFpEF currently. Sacubitril/vals...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yanhong, Ren, Mingjing, Wang, Tingting, Wang, Yulin, Pu, Tian, Li, Xiaodan, Yu, Lu, Wang, Liuwei, Liu, Peipei, Tang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681904/
https://www.ncbi.nlm.nih.gov/pubmed/36440034
http://dx.doi.org/10.3389/fcvm.2022.955780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681904/
https://www.ncbi.nlm.nih.gov/pubmed/36440034
http://dx.doi.org/10.3389/fcvm.2022.955780

Ejemplares similares